
Patent Ruling Shakes CureVac's Lawsuit Against BioNTech: A Turning Point in the Battle of mRNA
In a significant ruling on December 19, 2023, the German patent court invalidated a crucial patent that formed the core of CureVac's lawsuit against BioNTech, causing a notable impact on the stock market. Following Presiding Judge Walter Schramm's…

